{{Rsnum
|rsid=2519974
|Gene=HS3ST2
|Chromosome=16
|position=22877865
|Orientation=minus
|GMAF=0.3287
|Gene_s=HS3ST2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 43.2 | 46.8 | 9.9
| HCB | 33.6 | 47.0 | 19.4
| JPT | 34.8 | 51.8 | 13.4
| YRI | 75.9 | 20.7 | 3.4
| ASW | 64.9 | 33.3 | 1.8
| CHB | 33.6 | 47.0 | 19.4
| CHD | 37.6 | 45.9 | 16.5
| GIH | 47.5 | 37.6 | 14.9
| LWK | 87.2 | 12.8 | 0.0
| MEX | 39.7 | 46.6 | 13.8
| MKK | 82.1 | 17.9 | 0.0
| TSI | 41.2 | 48.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=4E-6
  |OR=1.65
  |ORtxt=[1.264-2.146]
  }}

{{PMID Auto
|PMID=19875614
|Title=A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}